ALKERMES INC
10-C, 1996-05-20
PHARMACEUTICAL PREPARATIONS
Previous: TOPRO INC, 10QSB, 1996-05-20
Next: MICEL CORP, 10QSB, 1996-05-20



<PAGE>
 
                                   Form 10-C

                       Securities and Exchange Commission
                              Washington, DC 20549

Report by issuer of securities quoted on The Nasdaq Stock Market, filed
pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule
13a-17 or 15d-17 thereunder.

EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER:      Alkermes, Inc.
                                              ----------------------------------

ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: 64 Sidney Street, Cambridge, Mass. 02139
                                        ----------------------------------------
                                                                                
ISSUER'S TELEPHONE NUMBER (INCLUDING AREA CODE): (617) 494-0171                 
                                                 -------------------------------

I.  Change in Number of Shares Outstanding
Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding:

1.  Title of security   Common Stock
                      ----------------------------------------------------------
 
2.  Number of shares outstanding before the  change  15,986,832
                                                   -----------------------------
3.  Number of shares outstanding after the change  18,286,832
                                                 -------------------------------
4.  Effective date of change  May 13, 1996 and May 14, 1996
                            ----------------------------------------------------
 
5.  Method of change  public offering
                    ------------------------------------------------------------

Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)
--------------------------------------------------------------------------------
Give brief description of transaction  2,300,000 shares of Common Stock sold
                                      ------------------------------------------
                                       directly by Company to several 
                                       institutional investors.
                                      ------------------------------------------
II.  Change in Name of Issuer

1.  Name prior to change
                        --------------------------------------------------------
2.  Name after change
                     -----------------------------------------------------------

3.  Effective date of charter amendment changing name
                                                     ---------------------------

4.  Date of shareholder approval of change, if required 
                                                       -------------------------

May 14, 1996                                       /s/ Michael J. Landine
--------------------------------------------------------------------------------
DATE            OFFICER'S SIGNATURE AND TITLE          Michael J. Landine
                                                       Senior Vice President and
                                                       Chief Financial Officer 
                                          


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission